Mike Crapo said...

When we talk about the need for greater transparency in the drug supply chain, that term can and should mean a few diffe...

I encourage you to recognize that Congress has the authority to make this determination.

I strongly suggest you accelerate your timeline and return to this committee in short order with an actual plan.

We need to identify avenues for lowering out-of-pocket costs, increasing competition, and promoting access to lifesaving...